Swiss orthopedic company Medartis reported robust business momentum during the first six months of 2026, driven by strong growth across its core markets. Following the solid performance in the first half of the year, management has revised its full-year revenue expectations upward.
Further details regarding the updated financial guidance and specific segmental performances are expected to be released alongside the company's comprehensive half-year financial report.
